CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA

被引:35
作者
Martin, Genevieve E. [1 ]
Pace, Matthew [1 ]
Thornhill, John P. [1 ,2 ]
Phetsouphanh, Chansavath [1 ]
Meyerowitz, Jodi [1 ]
Gossez, Morgane [1 ]
Brown, Helen [1 ]
Olejniczak, Natalia [1 ]
Lwanga, Julianne [3 ]
Ramjee, Gita [4 ]
Kaleebu, Pontiano [5 ]
Porter, Kholoud [6 ]
Willberg, Christian B. [1 ,7 ]
Klenerman, Paul [1 ,7 ]
Nwokolo, Nneka [8 ]
Fox, Julie [3 ]
Fidler, Sarah [2 ]
Frater, John [1 ,7 ]
机构
[1] Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford, England
[2] Imperial Coll, Wright Fleming Inst, Div Med, London, England
[3] Guys & St Thomas NHS Fdn Trust, Dept Genitourinary Med & Infect Dis, London, England
[4] South African Med Res Council, HIV Prevent Res Unit, Durban, South Africa
[5] Uganda Virus Res Inst MRC, Entebbe, Uganda
[6] UCL, Res Dept Infect & Populat Hlth, London, England
[7] Univ Oxford, NIHR Biomed Res Ctr, Oxford, England
[8] Chelsea & Westminster Hosp, London, England
基金
英国医学研究理事会;
关键词
HIV; reservoir; CD32; primary HIV infection; HIV DNAIN; ANTIRETROVIRAL THERAPY; EXPRESSION; RESERVOIR; INFECTION; ACTIVATION; RECEPTORS; SUBPOPULATIONS; PERSISTENCE; TRANSITION; MECHANISM;
D O I
10.3389/fimmu.2018.00928
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Efforts to both characterize and eradicate the HIV reservoir have been limited by the rarity of latently infected cells and the absence of a specific denoting biomarker. CD32a (Fc gamma RIIa) has been proposed to be a marker for an enriched CD4 T cell HIV reservoir, but this finding remains controversial. Here, we explore the expression of CD32 on CD3(+)CD4(+) cells in participants from two primary HIV infection studies and identify at least three distinct phenotypes (CD32(low), CD32(+)CD14(+), and CD32(high)). Of note, CD4 negative enrichment kits remove the majority of CD4(+)CD32(+) T cells, potentially skewing subsequent analyses if used. CD32high CD4 T cells had higher levels of HLA-DR and HIV co-receptor expression than other subsets, compatible with their being more susceptible to infection. Surprisingly, they also expressed high levels of CD20, TCR alpha beta, IgD, and IgM (but not IgG), markers for both T cells and naive B cells. Compared with other populations, CD32(low) cells had a more differentiated memory phenotype and high levels of immune checkpoint receptors, programmed death receptor-1 (PD-1), Tim-3, and TIGIT. Within all three CD3(+)CD4(+)CD32(+) phenotypes, cells could be identified in infected participants, which contained HIV DNA. CD32 expression on CD4 T cells did not correlate with HIV DNA or cell-associated HIV RNA (both surrogate measures of overall reservoir size) or predict time to rebound viremia following treatment interruption, suggesting that it is not a dominant biomarker for HIV persistence. Our data suggest that while CD32(+) T cells can be infected with HIV, CD32 is not a specific marker of the reservoir although it might identify a population of HIV enriched cells in certain situations.
引用
收藏
页数:13
相关论文
共 44 条
[21]   Immunological biomarkers predict HIV-1 viral rebound after treatment interruption [J].
Hurst, Jacob ;
Hoffmann, Matthias ;
Pace, Matthew ;
Williams, James P. ;
Thornhill, John ;
Hamlyn, Elizabeth ;
Meyerowitz, Jodi ;
Willberg, Chris ;
Koelsch, Kersten K. ;
Robinson, Nicola ;
Brown, Helen ;
Fisher, Martin ;
Kinloch, Sabine ;
Cooper, David A. ;
Schechter, Mauro ;
Tambussi, Giuseppe ;
Fidler, Sarah ;
Babiker, Abdel ;
Weber, Jonathan ;
Kelleher, Anthony D. ;
Phillips, Rodney E. ;
Frater, John .
NATURE COMMUNICATIONS, 2015, 6
[22]   Progressive contraction of the latent HIV reservoir around a core of less-differentiated CD4+ memory T Cells [J].
Jaafoura, S. ;
de Herve, M. G. de Goer ;
Hernandez-Vargas, E. A. ;
Hendel-Chavez, H. ;
Abdoh, M. ;
Mateo, M. C. ;
Krzysiek, R. ;
Merad, M. ;
Seng, R. ;
Tardieu, M. ;
Delfraissy, J. F. ;
Goujard, C. ;
Taoufik, Y. .
NATURE COMMUNICATIONS, 2014, 5
[23]   Antiretroviral Therapy Initiated Within 6 Months of HIV Infection Is Associated With Lower T-Cell Activation and Smaller HIV Reservoir Size [J].
Jain, Vivek ;
Hartogensis, Wendy ;
Bacchetti, Peter ;
Hunt, Peter W. ;
Hatano, Hiroyu ;
Sinclair, Elizabeth ;
Epling, Lorrie ;
Lee, Tzong-Hae ;
Busch, Michael P. ;
McCune, Joseph M. ;
Pilcher, Christopher D. ;
Hecht, Frederick M. ;
Deeks, Steven G. .
JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (08) :1202-1211
[24]   Low copy target detection by Droplet Digital PCR through application of a novel open access bioinformatic pipeline, 'definetherain' [J].
Jones, Mathew ;
Williams, James ;
Gaertner, Kathleen ;
Phillips, Rodney ;
Hurst, Jacob ;
Frater, John .
JOURNAL OF VIROLOGICAL METHODS, 2014, 202 :46-53
[25]   Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection [J].
Jones, R. Brad ;
Ndhlovu, Lishomwa C. ;
Barbour, Jason D. ;
Sheth, Prameet M. ;
Jha, Aashish R. ;
Long, Brian R. ;
Wong, Jessica C. ;
Satkunarajah, Malathy ;
Schweneker, Marc ;
Chapman, Joan M. ;
Gyenes, Gabor ;
Vali, Bahareh ;
Hyrcza, Martin D. ;
Yue, Feng Yun ;
Kovacs, Colin ;
Sassi, Aref ;
Loutfy, Mona ;
Halpenny, Roberta ;
Persad, Desmond ;
Spotts, Gerald ;
Hecht, Frederick M. ;
Chun, Tae-Wook ;
McCune, Joseph M. ;
Kaul, Rupert ;
Rini, James M. ;
Nixon, Douglas F. ;
Ostrowski, Mario A. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (12) :2763-2779
[26]   Expansion of CD8+ T cells that express low levels of the B cell-specific molecule CD20 in patients with multiple myeloma [J].
Katopodis, O ;
Liossis, SN ;
Viglis, V ;
Pouli, A ;
Dimopoulos, MA ;
Sfikakis, PP .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (03) :478-481
[27]  
Martin G. E, 2017, BIORXIV, DOI DOI 10.1101/169342
[28]   Fcγ receptors as regulators of immune responses [J].
Nimmerjahn, Falk ;
Ravetch, Jeffrey V. .
NATURE REVIEWS IMMUNOLOGY, 2008, 8 (01) :34-47
[29]   Dissection of a circulating CD3+CD20+ T cell subpopulation in patients with psoriasis [J].
Niu, J. ;
Zhai, Z. ;
Hao, F. ;
Zhang, Y. ;
Song, Z. ;
Zhong, H. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 192 (02) :206-212
[30]   Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients [J].
Palanichamy, Arumugam ;
Jahn, Sarah ;
Nickles, Dorothee ;
Derstine, Mia ;
Abounasr, Aya ;
Hauser, Stephen L. ;
Baranzini, Sergio E. ;
Leppert, David ;
von Buedingen, H. -Christian .
JOURNAL OF IMMUNOLOGY, 2014, 193 (02) :580-586